Lucknow’s Central Drug Research Institute (CDRI) has come out with an oral pill that might help fasten the process of healing after a fracture. The institution is currently working on two bone healing entities, namely CDRI-1500 and CDRI-399. Necessary approvals from drug regulatory bodies have been received and the phase-1 clinical trials for CDRI-1500 will begin soon.
Tests show that the drug has therapeutic potential and can work as a rapid fracture repairing agent. It can also help improve bone health in the management of osteoporosis and other bone-related disorders.
“Pharmacological data suggests that S007-1500 possesses potential osteogenic property and shows accelerated fracture repairing by significantly increasing the callus formation at the fracture site in the test models,” CDRI wrote.
CDRI-1500 is being said to be safe, economical and the first-of-its-kind.
Knocksense Shorts | Lucknow’s CIMAP to develop high-value phytomolecules for medicinal use
